2BBBullish & Bearish
Niagen Bioscience, Inc. (NAGE) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 34 out of 100.
Niagen Bioscience, formerly ChromaDex, is a bioscience сompany based in Los Angeles, California founded in 1999. The company operates in multiple sectors including reference standards, dietary supplements, and ingredient technology. Niagen Bioscience is publicly traded on the NASDAQ.
Niagen Bioscience, Inc.’s current 2BB score is 34 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 17 | Very Low |
| Momentum | 27 | Weakening |
| Financial strength | 64 | Strong |
| Quality | 100 | Very Strong |
| Risk | 39 | Low |
| Headquarters | Los Angeles, California, United States |
| Founded | 1999 |
| Employees | 117 |
| 52-week range | $2.87 – $10.52 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2026-11-02 | — | 0.0102 | — | $34.43M |
| 2026-08-04 | — | 0.0204 | — | $31.30M |
| 2026-05-06 | 0.07 | 0.0694 | $31.47M | $31.57M |
| 2026-03-04 | 0.03 | 0.0224 | $33.84M | $32.34M |